2022
Cigarette Smoking in Response to COVID-19: Examining Co-Morbid Medical Conditions and Risk Perceptions
Fucito LM, Bold KW, Cannon S, Serrantino A, Marrero R, O’Malley S. Cigarette Smoking in Response to COVID-19: Examining Co-Morbid Medical Conditions and Risk Perceptions. International Journal Of Environmental Research And Public Health 2022, 19: 8239. PMID: 35886090, PMCID: PMC9317071, DOI: 10.3390/ijerph19148239.Peer-Reviewed Original ResearchConceptsChronic medical conditionsMedical conditionsCigarette smokingCOVID-19 risk perceptionCOVID-19 riskGreater oddsSmoking changesHigher COVID-19 risk perceptionsCo-morbid medical conditionsCOVID-19Tobacco cessation treatmentCoronavirus disease 2019 (COVID-19) pandemicDisease 2019 pandemicPublic health threatCessation treatmentMedical historyWhite raceSmokingSmoking behaviorSample of adultsOngoing COVID-19Younger ageLogistical regressionHealth threatPreventive healthcare
2018
Chapter 12 Tobacco Use Disorder and Treatment
Fucito L, Baldassarri S. Chapter 12 Tobacco Use Disorder and Treatment. 2018, 183-196. DOI: 10.1016/b978-0-323-48565-4.00012-6.Peer-Reviewed Original ResearchTobacco use disorderLung cancer outcomesUse disordersOncology providersTobacco cessationCancer outcomesLung cancerTobacco useLong-term quit ratesBrief cessation adviceTobacco cessation interventionsTobacco cessation treatmentClinical practice guidelinesLung cancer patientsMajor risk factorLung cancer riskImportant teachable momentTobacco use statusCessation advicePharmacologic treatmentCessation treatmentWorse prognosisCessation interventionsCessation supportEfficient intervention strategies